Cargando…

Probiotic Lactobacillus Species and Their Biosurfactants Eliminate Acinetobacter baumannii Biofilm in Various Manners

Acinetobacter baumannii is a critical biofilm-forming pathogen that has presented great challenges in the clinic due to multidrug resistance. Thus, new methods of intervention are needed to control biofilm-associated infections. In this study, among three tested Lactobacillus species, Lactobacillus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Shamiri, Mona Mohamed, Wang, Jingdan, Zhang, Sirui, Li, Pu, Odhiambo, Woodvine Otieno, Chen, Yanjiong, Han, Bei, Yang, E., Xun, Meng, Han, Lei, Han, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100725/ https://www.ncbi.nlm.nih.gov/pubmed/36920192 http://dx.doi.org/10.1128/spectrum.04614-22

Ejemplares similares

Uncovering the Secretion Systems of Acinetobacter baumannii: Structures and Functions in Pathogenicity and Antibiotic Resistance
por: Li, Pu, et al.
Publicado: (2023)

The optimized carbapenem inactivation method for objective and accurate detection of carbapenemase-producing Acinetobacter baumannii
por: Zhang, Sirui, et al.
Publicado: (2023)

An Outer Membrane Protein YiaD Contributes to Adaptive Resistance of Meropenem in Acinetobacter baumannii
por: Han, Lei, et al.
Publicado: (2022)

Simultaneous Production of Biosurfactants and Bacteriocins by Probiotic Lactobacillus casei MRTL3
por: Sharma, Deepansh, et al.
Publicado: (2014)

Biosurfactant from Nile Papyrus endophyte with potential antibiofilm activity against global clones of Acinetobacter baumannii
por: Amer, Mai A., et al.
Publicado: (2023)

Influence of Lactobacillus Biosurfactants on Skin Permeation of Hydrocortisone
por: Abruzzo, Angela, et al.
Publicado: (2021)

bla(OXA-23-like) and bla(TEM) rather than bla(OXA-51-like) contributed to a high level of carbapenem resistance in Acinetobacter baumannii strains from a teaching hospital in Xi’an, China
por: Han, Lei, et al.
Publicado: (2017)

Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics
por: Ng, Say Yong, et al.
Publicado: (2020)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Production and Structural Characterization of Lactobacillus helveticus Derived Biosurfactant
por: Sharma, Deepansh, et al.
Publicado: (2014)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

Protein Aggregation is Associated with Acinetobacter baumannii Desiccation Tolerance
por: Wang, Xun, et al.
Publicado: (2020)

Biosurfactant derived from probiotic Lactobacillus acidophilus exhibits broad-spectrum antibiofilm activity and inhibits the quorum sensing-regulated virulence
por: Adnan, Mohd, et al.
Publicado: (2023)

167. Probiotics And Probiotic Biosurfactants Inhibit S. Aureus Biofilms On Acellular Dermal Matrix
por: Pennypacker, Sarah D., et al.
Publicado: (2023)

Functional characterization of biomedical potential of biosurfactant produced by Lactobacillus helveticus
por: Sharma, Deepansh, et al.
Publicado: (2016)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia
por: Gu, Zhenyang, et al.
Publicado: (2016)

Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
por: Xiao, Shu-Zhen, et al.
Publicado: (2016)

Synergistic Effects of a Probiotic Culture Extract and Antimicrobial Combinations against Multidrug-Resistant Acinetobacter baumannii
por: Lee, Ji Hyeon, et al.
Publicado: (2023)

Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone
por: Corazza, Elisa, et al.
Publicado: (2022)

Functional Characterization of Acinetobacter baumannii Lacking the RNA Chaperone Hfq
por: Kuo, Han-Yueh, et al.
Publicado: (2017)

Novel Phage Lysin Abp013 against Acinetobacter baumannii
por: Chu, Joash Jun Keat, et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Acinetobacter baumannii in Human Body Louse
por: La Scola, Bernard, et al.
Publicado: (2004)

Acinetobacter baumannii: An emerging opportunistic pathogen
por: Howard, Aoife, et al.
Publicado: (2012)

Reservoirs of Non-baumannii Acinetobacter Species
por: Al Atrouni, Ahmad, et al.
Publicado: (2016)

Iron and Acinetobacter baumannii Biofilm Formation
por: Gentile, Valentina, et al.
Publicado: (2014)

The Mechanisms of Disease Caused by Acinetobacter baumannii
por: Morris, Faye C., et al.
Publicado: (2019)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Structure and Evolution of Acinetobacter baumannii Plasmids
por: Salgado-Camargo, Abraham D., et al.
Publicado: (2020)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Molecular characterisation of an Acinetobacter baumannii outbreak
por: Al-Hassan, Leena L., et al.
Publicado: (2020)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8l1hb7h9tlr8k2kt7vq11mms0v